Erleada 60 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB26FGLYS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,559
Award facts
- Contract value 100% obligated
- $7,558.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $7,558.79, awards AmerisourceBergen Drug Corp the supply of Erleada 60 mg tablets (120 tablets) under a firm fixed price contract with the Defense Logistics Agency (DLA). The award was made on October 21, 2025, with an ultimate completion date of November 12, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive product portfolio to fulfill defense medical supply requirements. The DLA's medical supply chain utilizes AmerisourceBergen's extensive capabilities in pharmaceutical distribution, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The broader SPE2DX contract vehicle enables AmerisourceBergen to support customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key vendor in the DLA's Pharmaceutical Prime Vendor program, with plans underway for establishing Generation V contracts across multiple global regions.
Quick answers
Who was awarded contract SPE2DB26FGLYS?
SPE2DB26FGLYS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FGLYS worth?
The government has obligated $7,559 on SPE2DB26FGLYS.
Is contract SPE2DB26FGLYS an order under another contract?
Yes. SPE2DB26FGLYS is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB26FGLYS competed?
The extent of competition for SPE2DB26FGLYS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award